Appetite stimulants

Cannabix Technologies Develops Version 2.0 of THC Breath Analyzer

Retrieved on: 
Monday, May 11, 2020
Drugs, Psychoactive drugs, Appetite stimulants, Entheogens, Euphoriants, Medicine, Cannabis smoking, Medicinal plants, Cannabis, Tetrahydrocannabinol, Driving under the influence, Cannabinol

Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.

Key Points: 
  • Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.
  • The THCBA incorporates microfluidic sensor technology for the detection of THC from breath.
  • The THCBA uses a disposable spit trap and provides easy to understand screen prompts for the positive and negative detection of THC in breath.
  • Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples.

Magic Mushroom Advocates Seek to Emulate the Rise of CBD

Retrieved on: 
Thursday, May 7, 2020
Medicine, Herbalism, Medicinal plants, Drugs, Antiemetics, Health sciences, Appetite stimulants, Entheogens, Medical cannabis, Cannabis, Tetrahydrocannabinol, CBD

"CBD is sort of stuck in between prohibition era policies and federal acceptance.

Key Points: 
  • "CBD is sort of stuck in between prohibition era policies and federal acceptance.
  • We just saw the first cannabis derived FDA approved medication make its way onto the market, which is a CBD medication.
  • Seniors are more keen to try a CBD product over a THC product, so even on the regular non-pharmaceutical market, CBD will still snag a good portion of untapped market share.
  • International trade of source material is another big advantage of the CBD market, to help it grow."

Magic Mushroom Advocates Seek to Emulate the Rise of CBD

Retrieved on: 
Thursday, May 7, 2020
Medicine, Herbalism, Medicinal plants, Drugs, Antiemetics, Health sciences, Appetite stimulants, Entheogens, Medical cannabis, Cannabis, Tetrahydrocannabinol, CBD

"CBD is sort of stuck in between prohibition era policies and federal acceptance.

Key Points: 
  • "CBD is sort of stuck in between prohibition era policies and federal acceptance.
  • We just saw the first cannabis derived FDA approved medication make its way onto the market, which is a CBD medication.
  • Seniors are more keen to try a CBD product over a THC product, so even on the regular non-pharmaceutical market, CBD will still snag a good portion of untapped market share.
  • International trade of source material is another big advantage of the CBD market, to help it grow."

InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference

Retrieved on: 
Thursday, May 7, 2020
Cannabis smoking, Psychoactive drugs, Health, Cannabinoids, Drugs, Natural phenols, Appetite stimulants, Entheogens, INMED, CBN, Cannabinol, Effects of cannabis

A. Adams, President & CEO of InMed, will present a corporate overview as part of the upcoming virtual conference:

Key Points: 
  • A. Adams, President & CEO of InMed, will present a corporate overview as part of the upcoming virtual conference:
    Canaccord Genuity's 4th Annual Cannabis Conference on Tuesday, May 12th, 2020 at
    12:00 PM PST / 3:00 PM EST.
  • A webcast of the presentation will be available at: http://wsw.com/webcast/canaccord39/imlff as well as from the Investor page of the InMed website at https://investors.inmedpharma.com/ .
  • About InMed: InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.
  • Cautionary Note Regarding Forward-Looking Information:
    This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws.

Cativa CBD Introduces Two New CBD-infused Drinks

Retrieved on: 
Wednesday, May 6, 2020
Drugs, Organ systems, Psychoactive drugs, Cannabinoids, Resorcinols, Entheogens, Euphoriants, Appetite stimulants, Cannabidiol, Tetrahydrocannabinol, CBD, MG

PORTSMOUTH, Va., May 6, 2020 /PRNewswire-PRWeb/ -- Cativa Health ("Cativa CBD"), a science-based cannabidiol (CBD) brand revolutionizing the wellness and CBD industries, announced the launch of its CBD-infused Iced Coffee and a CBD Hibiscus Tea.

Key Points: 
  • PORTSMOUTH, Va., May 6, 2020 /PRNewswire-PRWeb/ -- Cativa Health ("Cativa CBD"), a science-based cannabidiol (CBD) brand revolutionizing the wellness and CBD industries, announced the launch of its CBD-infused Iced Coffee and a CBD Hibiscus Tea.
  • "Our mission at Cativa CBD is to bring health and wellness to people through science," said Luisa Escobar Worrell, the Chief Operating Officer of Cativa CBD.
  • Alongside these beverages, Cativa offers the following to provide a holistic approach to CBD health:
    Restore CBD Body Cream, an ultra-moisturizing and restorative CBD body cream that contains up to 200 mg of CBD per bottle.
  • Founded in 2018, Cativa CBD is dedicated to using the latest in cutting-edge technology and zero-THC CBD isolates.

Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids

Retrieved on: 
Wednesday, May 6, 2020
Cannabinoids, Entheogens, Euphoriants, Antiemetics, Appetite stimulants, Medical specialties

TEL AVIV, IsraelandBETHESDA, Maryland, May 6, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has filed a Provisional Patent Application with the US Patent & Trademark Office (USPTO) entitled "Composition and Method for Treating Colon Cancer with Cannabinoids".

Key Points: 
  • TEL AVIV, IsraelandBETHESDA, Maryland, May 6, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has filed a Provisional Patent Application with the US Patent & Trademark Office (USPTO) entitled "Composition and Method for Treating Colon Cancer with Cannabinoids".
  • Having demonstrated complex combinatorial anti-tumor effects and lacking psychoactive effects, the composition may enable patients to be treated with high dosages without intoxication.
  • By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy.
  • For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Instagram @Cannabics_Pharmaceuticals.

Health and Wellness Company Launches Pre-IPO Funding Round with Brokers Crowdfunder.com

Retrieved on: 
Wednesday, May 6, 2020
Appetite stimulants, Entheogens, Euphoriants, Drugs, Medical specialties, Medicine, Biofuels, Hemp, Herbs, Cannabis, Tetrahydrocannabinol

Of their children, three struggle with ADHD and two participate in high-level athletics, which means sports injuries are not uncommon in their households.

Key Points: 
  • Of their children, three struggle with ADHD and two participate in high-level athletics, which means sports injuries are not uncommon in their households.
  • The two fathers had explored a range of natural remedies and eventually discovered the health benefits of hemp CBD.
  • During the current pandemic crisis, Life Pack Organics products can also be a great line of defense as an immunity booster.
  • Life Pack Organics is a Los Angeles-based health & wellness company specializing in science-based organic products infused with broad-spectrum CBD with Zero THC.

Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine

Retrieved on: 
Tuesday, May 5, 2020
Smoking, Tobacco, Medicine, Appetite stimulants, Entheogens, Euphoriants, Electronic cigarettes, Cannabis smoking, Electronic cigarette, Cannabis, Tetrahydrocannabinol, Hair analysis

This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking.

Key Points: 
  • This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking.
  • Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.
  • Underscoring the evolving nature of the threat, THC (the psychotic substance in marijuana) and CBD are increasingly popular vaping choices among teens.
  • Psychemedics is the standard against which all others measure themselves for sensitivity, quality, and innovation to stay ahead of the ever-changing illicit drug landscape.

Cannabis Global Announces Significant Breakthrough in Study Involving THC-V Infusion Technologies for Beverages

Retrieved on: 
Thursday, April 30, 2020
Entheogens, Euphoriants, Medicinal plants, Herbs, Plants, Appetite stimulants, Psychoactive drugs, Cannabis, Hemp, Rosids

"While these developments add to our growing list of intellectual property, theseare much more than technologies that will sit on a shelf,"commented Arman Tabatabaei, CEO of Cannabis Global.

Key Points: 
  • "While these developments add to our growing list of intellectual property, theseare much more than technologies that will sit on a shelf,"commented Arman Tabatabaei, CEO of Cannabis Global.
  • The Company utilized both botanically derived and pharmaceutical-grade synthetic tetrahydrocannabinol to develop these infusion technologies.
  • Cannabis Global, Inc. ( MCTC ) is a Nevada registered, fully reporting and audited publicly-traded company.
  • With the hemp and cannabis industries movingvery quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain.

University of Wisconsin partners with CytoCBD to study Cannabidiol & its clinical effects on humans

Retrieved on: 
Tuesday, April 28, 2020
Health, Medicine, Cannabis smoking, Herbalism, Medicinal plants, Clinical research, Appetite stimulants, Cannabis, Effects of cannabis, Medical cannabis, Clinical trial

To do this, scientific studies and clinical trials have come to the forefront in the medical research of CBD.

Key Points: 
  • To do this, scientific studies and clinical trials have come to the forefront in the medical research of CBD.
  • Dr. Natalie Schmitz spearheads the research at UW and has unique expertise, previously having worked as a Medical Cannabis Pharmacist.
  • "After speaking with many CBD companies, CytoCBD stood out to our team as they really understood the clinical science and nature behind their products.
  • For more information on the clinical trials at the University of Wisconsin, please contact: [email protected]
    For more information on CytoCBD and their products, please visit http://www.cytocbd.com or email [email protected]